ORIFARM NORWAY AS

Signals

1 flags

• ▼ Driftsunderskudd 2024 Siste driftsresultat er negativt (−1,8 mrd kr).

ORIFARM NORWAY AS is registered as a limited company in Oslo, Oslo with organisation number 924595388. The business is classified under wholesale of pharmaceutical and medical goods (NACE 46.460). The company was incorporated in 2020. Registered share capital is NOK 30,000, divided into 300 shares. The company's stated purpose is: “Industri, handel og annen virksomhet som angår disse formål.”. The most recent filed accounts, for the 2024 financial year, show NOK 142.0m in revenue and NOK −1.8bn in operating profit.

Key figures · 2024

Revenue

NOK 142.0m

Operating profit

NOK −1.8bn

Equity

NOK 9.3bn

Est. value

NOK 57.2bn

Financial health · 2024

Liquidity

4.80

Very good

Current assets ÷ current liabilities

Profitability

–

Not available

Return on total assets

Solidity

4.8%

Weak

Equity as a share of total capital

Who owns ORIFARM NORWAY AS?

ORIFARM GROUP AS

100.0%

ORIFARM NORWAY AS

NOK 142.0m rev. · NOK −1.8bn profit

ORIFARM NORWAY AS has 1 registered shareholder:

• ORIFARM GROUP AS 100.0%

All shareholders and roles →

Frequently asked questions about ORIFARM NORWAY AS

Who owns ORIFARM NORWAY AS?

ORIFARM GROUP AS is the largest registered owner, with 100.0%.

What is the revenue of ORIFARM NORWAY AS?

ORIFARM NORWAY AS had revenue of NOK 142.0m in 2024.

Who is the general manager of ORIFARM NORWAY AS?

Sverre Haugen is registered as general manager of ORIFARM NORWAY AS.

Where is ORIFARM NORWAY AS based?

ORIFARM NORWAY AS has its business address in Oslo.

Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.